Kyrgyzstan Medical Device Certificate Duplicate Issuance and Cancellation: Procedures and Implications
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The duplicate issuance and cancellation of a Kyrgyzstan registration certificate, like registration and amendment, require an application in the prescribed format processed in the IS EBD LS i MI electronic system. The competent authority has published two corresponding forms: Annex 3 (cancellation application form) and Annex 4 (registration certificate format). Duplicate issuance answers the question of what to do when a certificate is lost; cancellation answers the question of what to do when a product is withdrawn. The latter is used upon product discontinuation, entity changes, or shifts in market strategy. It is a procedural action, but it likewise must pass through the competent authority.
2. Legal basis
- Public forms of the competent authority, Annex 3: format of the application form for cancellation (annulment) of a registration certificate.
- Public forms of the competent authority, Annex 4: registration certificate format.
- Public forms of the competent authority, Annex 2: application form for amendments of the registration dossier.
- Published position of the competent authority: all procedures for registration, amendment, suspension, and cancellation (annulment) of registration certificates are handled in the IS EBD LS i MI system.
- Cabinet Resolution No. 513, August 27, 2024, Annex 1, Article 1: the procedure governs amendments of the registration dossier and suspension or revocation of registration certificates.
- Law No. 216, Article 15: circumstances for suspension and revocation of registration certificates.
3. Expert insights
Insight 1: cancellation splits into application-based and authority-initiated types, and their nature is entirely different.
Annex 3 published by the competent authority is the channel for application-based cancellation, initiated by the holder, typically upon product discontinuation, cessation of supply, or restructuring of entities. Authority-initiated cancellation is a regulatory action under Article 15 of Law No. 216, triggered by circumstances including the provision of false information, an effective court judgment, new systematic data showing risks outweighing benefits, and unresolved grounds for suspension. The legal consequence is identical, the certificate ceases to be valid, but the nature and the after-effects differ sharply: application-based cancellation is a commercial decision, while authority-initiated cancellation carries a compliance record.
Insight 2: before cancelling, settle first how product in circulation will be handled.
Cancellation removes the legal basis for the product to circulate in Kyrgyzstan. On sequencing we recommend: dispose of inventory and channels first, then apply for cancellation. If cancellation comes first, the remaining products on the market will lack the support of a registration certificate, which may trigger circulation violations.
Insight 3: the value of duplicate issuance may decline once electronic certificates roll out.
The 2026 amendment draft of the competent authority proposes issuing registration certificates in electronic format (draft status). If electronic certificates land, the ground of lost original will shrink dramatically, because the electronic record itself is the proof. We recommend tracking this change and adjusting internal document management and customer response processes in advance (see Part 13 of this series).
Insight 4: suspension and cancellation are two tiers, and a cancellation application can also serve as a loss-containment tool.
As discussed in Part 08 of this series, suspension is temporary and lifts once the ground is removed, while cancellation is final. Where the risk of authority-initiated cancellation is high, for example when a material discrepancy in the declared information has been found, proactively applying for cancellation and reapplying may be the more controllable path. This judgment must be made in light of the specific circumstances and local counsel’s view.
Insight 5: re-entering the market after cancellation is treated as a new registration.
Cancellation is final; there is no reinstatement. If the product is to re-enter the Kyrgyz market later, it must go through a new registration. This means a cancellation decision should consider the three-to-five-year market plan. Especially given that after 2028 a new registration can only go through the Union track, the cost of coming back after cancellation rises significantly.
4. Practical recommendations
First, distinguish the two cancellation types and prepare materials separately. Application-based cancellation: the cancellation application form, the original certificate if available, a statement of reasons, and a disposition plan for inventory and channels. Authority-initiated cancellation: enter the emergency response process, assess whether the ground can be removed, and whether remediation is possible during suspension.
Second, dispose of inventory and channels before applying for cancellation. We recommend completing inventory counting, channel notification, and recall arrangements before filing, so that no products without certificate support remain on the market.
Third, fold the cancellation decision into market planning. Before cancelling, assess whether a return within three to five years is plausible. If so, note that after 2028 a new registration can only go through the Union track, and the re-entry cost after cancellation rises significantly.
Fourth, track the rollout of electronic certificates and adjust internal processes. We recommend adjusting document management, customer response, and archiving practices in advance to prepare for electronic certificates (draft status).
Fifth, apply the consistency check to duplicate issuance and cancellation applications as well. We recommend reusing the standard wording table so that the device name, registration number, and holder information stated in the application match the registration dossier.
5. Verification checklist
- □ The cancellation application uses the current published Annex 3 form of the competent authority;
- □ Application-based and authority-initiated cancellation have been distinguished, with materials and response plans prepared for each;
- □ Inventory counting, channel notification, and recall arrangements were completed before cancellation;
- □ The cancellation decision has been tested against the three-to-five-year market plan, including the constraint that after 2028 only the Union track is available;
- □ The certificate format has been checked against Annex 4, and progress on electronic certificates is tracked (draft status);
- □ Duplicate issuance and cancellation applications have undergone the consistency check on device name, registration number, and holder information.
Regulatory information verified as of October 29, 2026.
Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system compliance coaching, post-market surveillance and vigilance system setup, import and distribution compliance, state fee estimation, and project budget management.
The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations. It maintains a stable local cooperation network in Bishkek, Almaty, Tashkent, Moscow, and other cities, and works in Chinese, Russian, and English. For the key issues that foreign manufacturers commonly face in CIS markets, including authorized representative arrangements, the notarization and legalization chain for powers of attorney, localization of technical documentation, and inspection response, GRZAN provides executable solutions.
We hold to one principle: every regulatory conclusion we publish must be traceable to verifiable official sources. Any figure or timeline that cannot be verified is always labeled as a practical estimate, and experience values are never presented as legal grounds.
GRZAN provides registration and compliance support in Kyrgyzstan for medical device manufacturers, importers, and authorized representatives. For project consultation on market access in Kyrgyzstan or the Eurasian Economic Union, please contact us at info@grzanglobal.com.
GRZAN | Global Medical Device Regulatory Registration and Compliance Services
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us